Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide
Crossref DOI link: https://doi.org/10.1007/s40262-016-0403-6
Published Online: 2016-04-22
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Benoist, Guillemette E.
Hendriks, Rianne J.
Mulders, Peter F. A.
Gerritsen, Winald R.
Somford, Diederik M.
Schalken, Jack A.
van Oort, Inge M.
Burger, David M.
van Erp, Nielka P.
License valid from 2016-04-22